These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2900302)

  • 1. Biochemical characterization of a new highly cardioselective beta-adrenoceptor antagonist.
    Gobbi M; Mennini T; Ratti E
    J Pharm Pharmacol; 1988 Apr; 40(4):243-6. PubMed ID: 2900302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of celiprolol (REV 5320), a new cardioselective beta-adrenoceptor antagonist, on in vitro adenylate cyclase, alpha- and beta-adrenergic receptor binding and lipolysis.
    Van Inwegen RG; Khandwala A; Weinryb I; Pruss TP; Neiss E; Sutherland CA
    Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):40-55. PubMed ID: 6151380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of cardiac beta-adrenoceptors using 125I-labelled 1-(4-iodophenoxy)-3-isopropylaminopropan-2-ol.
    Woodcock EA; Bobik A; Funder JW; Johnston CI
    Eur J Pharmacol; 1978 May; 49(1):73-80. PubMed ID: 26576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two beta-adrenergic pharmacophores on the same molecule. A set of agonist-antagonist combinations.
    Kusiak JW; Heja G; Pitha J
    Biochem Pharmacol; 1987 Jan; 36(2):269-75. PubMed ID: 2880591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioligand binding studies with 3-(4-(2-hydroxy-3-((1, 1-dimethylethyl)-amino)-propoxy)-phenyl)-7-methoxy-2-methyl- 1(2H)-isoquinolinone (HI-42), a new cardioselective beta-adrenoceptor blocker with long-lasting effects in vivo.
    Jackisch R; Lederle M; Hertting G
    Arzneimittelforschung; 1985; 35(1A):237-40. PubMed ID: 2859028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro characterization of skeletal muscle beta-adrenergic receptors coupled to adenylate cyclase.
    Reddy NB; Engel WK
    Biochim Biophys Acta; 1979 Jul; 585(3):343-59. PubMed ID: 226166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological properties of an extremely selective beta 1-adrenoceptor antagonist, 2-[4-[3-(tert-Butylamino)-2-hydroxypropoxy] phenyl]-3-methyl-6-methoxy-4(3H)-quinazolinone [+/-)HX-CH 44 BS).
    Daemmgen JW; Engelhardt G; Pelzer H
    Arzneimittelforschung; 1985; 35(1A):383-90. PubMed ID: 2859033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding characteristics of 3H-CGP12177 to beta-adrenoceptors in rat myocardial membranes.
    Tsuchihashi H; Yokoyama H; Nagatomo T
    Jpn J Pharmacol; 1989 Jan; 49(1):11-9. PubMed ID: 2566701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of beta-adrenoceptor subtype on rat isolated ventricular myocytes by use of highly selective beta-antagonists.
    Kitagawa Y; Adachi-Akahane S; Nagao T
    Br J Pharmacol; 1995 Sep; 116(1):1635-43. PubMed ID: 8564230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenylethanolaminotetralines compete with [3H]dihydroalprenolol binding to rat colon membranes without evidencing atypical beta-adrenergic sites.
    Landi M; Bianchetti A; Croci T; Manara L
    Biochem Pharmacol; 1992 Aug; 44(4):665-72. PubMed ID: 1354964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of beta 1- and beta 3-adrenoceptors in intact brown adipocytes of the rat.
    D'Allaire F; Atgié C; Mauriège P; Simard PM; Bukowiecki LJ
    Br J Pharmacol; 1995 Jan; 114(2):275-82. PubMed ID: 7881727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of beta-adrenoceptor antagonists to rat and rabbit lung: special reference to levobunolol.
    Quast U; Vollmer KO
    Arzneimittelforschung; 1984; 34(5):579-84. PubMed ID: 6147147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrinsic sympathomimetic activity of beta-adrenoceptor antagonists: down-regulation of cardiac beta 1- and beta 2-adrenoceptors.
    Reithmann C; Wieland F; Jakobs KH; Werdan K
    Eur J Pharmacol; 1989 Nov; 170(3):243-55. PubMed ID: 2575997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical evidence for the dual action of labetalol on alpha- and beta-adrenoceptors.
    Aggerbeck M; Guellaen G; Hanoune J
    Br J Pharmacol; 1978 Apr; 62(4):543-8. PubMed ID: 26446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bucindolol exerts agonistic activity on the propranolol-insensitive state of beta1-adrenoceptors in human myocardium.
    Bundkirchen A; Brixius K; Bölck B; Schwinger RH
    J Pharmacol Exp Ther; 2002 Mar; 300(3):794-801. PubMed ID: 11861783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Putrescine modulation of acute activation of the beta-adrenergic system in the left atrium of rat.
    Bordallo C; Cantabrana B; Velasco L; Secades L; Meana C; Méndez M; Bordallo J; Sánchez M
    Eur J Pharmacol; 2008 Nov; 598(1-3):68-74. PubMed ID: 18755180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences between the third cardiac beta-adrenoceptor and the colonic beta 3-adrenoceptor in the rat.
    Kaumann AJ; Molenaar P
    Br J Pharmacol; 1996 Aug; 118(8):2085-98. PubMed ID: 8864547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioselectivity of beta-adrenoceptor blocking agents 1. 1-[(4-Hydroxyphenethyl)amino]-3-(aryloxy)propan-2-ols.
    Rzeszotarski WJ; Gibson RE; Eckelman WC; Reba RC
    J Med Chem; 1979 Jun; 22(6):735-7. PubMed ID: 37339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affinities for alpha- and beta-adrenoceptor subtypes of YM-09538, a new combined alpha- and beta-adrenoceptor antagonist, by radioligand binding assay.
    Asano M; Hashimoto H; Nakashima M
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):34-46. PubMed ID: 6135396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and physiological effects of S-32-468, a beta-adrenoceptor antagonist with possible oculoselectivity.
    Nathanson JA
    Curr Eye Res; 1985 Mar; 4(3):191-7. PubMed ID: 2861973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.